Articles From: California Water Service Company (Cal Water) Provides Water Supply Update; Says Its Districts Are Prepared to Meet Customer Demand Despite Drought Emergency to Vertex Submits Supplemental New Drug Application (sNDA) to U.S. Food and Drug Administration for KALYDECO™ (ivacaftor) Monotherapy for People with Non-G551D Gating Mutations


2014/1/17
http://media.marketwire.com/attachments/200809/462952_GroupLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1082909&ProfileId=051205&sourceType=1 SAN JOSE, CA --
Sign-up for California Water Service Company (Cal Water) Provides Water Supply Update; Says Its Districts Are Prepared to Meet Customer Demand Despite Drought Emergency investment picks
Frontier Communications (NASDAQ:FTR), a leading provider of broadband, voice, data, and satellite television services, knows the holiday season is when online shoppers most need identity protection and computer back-up and sharing.
Sign-up for Frontier Communications Reassures Comcast Customers: “We have your back” investment picks
Multi-mode WCDMA/TD-SCDMA 3G quad-core smartphone chipset (SC8735S) now shipping in HTC Desire smartphones for China and greater Asia markets SHANGHAI , Dec.
Sign-up for Spreadtrum Launches Quad-Core 3G Smartphone Chipset Portfolio investment picks
Aeroflex Incorporated (“Aeroflex”), a wholly owned subsidiary of Aeroflex Holding Corp.
Sign-up for Aeroflex Announces New Vice President and COO for Aeroflex Microelectronic Solutions HiRel Businesses investment picks
2013/8/8
Medical Properties Trust, Inc. (the “Company”) (NYSE: MPW) today announced financial and operating results for the second quarter ended June 30, 2013.
Sign-up for Medical Properties Trust, Inc. Reports 9% Increase in Normalized FFO Per Share in Second Quarter 2013 investment picks
HealthLease Properties REIT Announces Acquisition from Mainstreet Property Group and Investment in New Development Fund, and Introduces New Trustee Canada NewsWire /NOT FOR DISSEMINATION IN THE UNITED STATES / CARMEL, IN , Dec.
Sign-up for HealthLease Properties REIT Announces Acquisition from Mainstreet Property Group and Investment in New Development Fund, and Introduces New Trustee investment picks
2013/12/18
DEERFIELD, Ill.
Sign-up for Mondelez International Announces Final Results of Cash Tender Offer investment picks
NEW YORK , Nov.
Sign-up for AllianceBernstein Closed-End Funds Announce Distribution Rates investment picks
Verizon Wireless: WHO: Verizon Wireless , operator of the nation’s largest 4G LTE network and largest, most reliable 3G network WHAT: Verizon Wireless recently enhanced fourth generation (4G) Long Term Evolution (LTE) network coverage within Springfield, Vermont.
Sign-up for Verizon Wireless Enhances 4G LTE Coverage in Springfield, Vermont investment picks
2013/10/23
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- After another record-setting day for the S&P 500 index, U.S. stock futures pointed to a softer open on Wednesday as investors prepared for a string of earnings reports, including Dow components Boeing Co.
Sign-up for Stock futures retreat with Boeing, CAT on tap investment picks
Tools for bottom-up collaboration and motivation are used infrequently by enterprises and to a lesser extent than traditional, top-down approaches RA'ANANA, Israel , July 31, 2013 /PRNewswire/ -- NICE Systems (NASDAQ: NICE) today announced that a benchmark study on trends and best practices in frontline performance management indicates that a majority of companies do not use collaboration and gamification to improve employee engagement.
Sign-up for NICE Benchmark Survey Highlights Opportunities for Service Organizations to Better Engage Employees investment picks
2014/1/13
- Joint development of Regeneron's PDGFR Beta antibody as new candidate for potential combination therapy demonstrates both companies' strong commitment to ophthalmology - Bayer obtains exclusive commercialization rights outside the U.S., where Bayer and Regeneron will share profits - Regeneron retains full U.S. commercialization rights TARRYTOWN, N.Y. , Jan.
Sign-up for Regeneron and Bayer to Develop New Treatment Option for Wet Age-Related Macular Degeneration investment picks
2014/2/4
By Saabira Chaudhuri J.P. Morgan Chase & Co.
Sign-up for J.P. Morgan Agrees to Pay $1.45 Million to Settle Sex Discrimination Lawsuit investment picks
2013/7/31
Seattle Genetics, Inc. (Nasdaq: SGEN) today reported financial results for the second quarter and six months ended June 30, 2013.
Sign-up for Seattle Genetics Reports Second Quarter 2013 Financial Results investment picks
By Ari Weinberg It was a heady year for ETFs.
Sign-up for Where the ETF money went in 2013 investment picks
2014/3/5
Wells Fargo & Company (NYSE: WFC ) announced today that it has formalized a team within its Corporate Banking Group to meet the banking needs of its large and complex for-profit healthcare customers.
Sign-up for Wells Fargo Corporate Banking Forms Healthcare Specialty Group investment picks
2014/2/5
Stratasys Ltd.
Sign-up for Stratasys Conference Call to Discuss Fourth Quarter and Full Year Financial Results investment picks
Leading Industry Analyst and NetSuite Customer, Collaborative Consulting to Share Insights and Best Practices on How Services Organizations Can Avoid the 'Empty Ritual' of Business Planning SAN MATEO, Calif.
Sign-up for NetSuite Customer To Demonstrate How To Turn Annual Planning Into A Catalyst For Growth For Professional Services Organizations investment picks
The New #1 Name in Music Will Appear on Channel 138 LIVERMORE, Calif.
Sign-up for Comcast to Make Sean Combs' New Music Channel, Revolt TV, Available in California on November 20th investment picks
Sturm, Ruger & Company, Inc. (NYSE:RGR) announced the promotion of Christopher J.
Sign-up for Ruger Announces Promotion of Christopher J. Killoy to President investment picks
By Rex Crum, MarketWatch SAN FRANCISCO (MarketWatch) -- Several leading Internet companies got the attention of investors Thursday following a lengthy report on the sector from Morgan Stanley that included an upgrade of Groupon Inc. and ratings cuts on OpenTable Inc. and Zillow Inc. Morgan Stanley analyst Scott Devitt assessed the opportunities for 24 Internet stocks in his report.
Sign-up for Groupon, OpenTable in Morgan Stanley's sights investment picks
By Sital S.
Sign-up for Trading glitches in focus at SEC, exchange meeting investment picks
Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, has filed its pre-Investigational New Drug (IND) meeting documents with the U.S. Food and Drug Administration (FDA). The company expects the pre-IND meeting to take place by the end of January 2014.
Sign-up for Harvard Apparatus Regenerative Technology Files Pre-IND Meeting Documents and Orphan Biologics Application with U.S. Food and Drug Administration investment picks
The Internal Revenue Service (IRS) today announced that it will begin processing tax returns on January 31, 2014.
Sign-up for Intuit TurboTax: First Filed, First Refunded investment picks
2014/1/27
The Smead Value Fund (Investor Share Class: SMVLX, Institutional Share Class: SMVMX) announces the launch of its A Share Class (SVFAX) effective January 24, 2014.
Sign-up for Smead Value Fund Launches Class A Shares investment picks
Sprint (NYSE: S ) demonstrated live today 1 Gigabit per second (Gbps) over-the-air speed at its lab near Silicon Valley, Calif.
Sign-up for Sprint Demonstrates 1 Gigabit Over-the-Air Speed at Silicon Valley Lab investment picks
The Board of Directors of Avery Dennison Corporation (NYSE:AVY) has declared a quarterly cash dividend of $0.29 per share.
Sign-up for Avery Dennison Declares Quarterly Dividend investment picks
2014/1/29
HOUSTON , Jan.
Sign-up for Prosperity Bancshares, Inc.® Announces Management Changes investment picks
Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX) today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for the approval of KALYDECO TM (ivacaftor) monotherapy for people with cystic fibrosis (CF) ages 6 and older who have at least one non-G551D gating mutation in the cystic fibrosis transmembrane conductance regulator ( CFTR ) gene.
Sign-up for Vertex Submits Supplemental New Drug Application (sNDA) to U.S. Food and Drug Administration for KALYDECO™ (ivacaftor) Monotherapy for People with Non-G551D Gating Mutations investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: California Water Service Company (Cal Water) Provides Water Supply Update; Says Its Districts Are Prepared to Meet Customer Demand Despite Drought Emergency to Vertex Submits Supplemental New Drug Application (sNDA) to U.S. Food and Drug Administration for KALYDECO™ (ivacaftor) Monotherapy for People with Non-G551D Gating Mutations
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity